Evidence map›Paper›PMID 11997522›Full record

ArticleMolecular and cellular biology2002

Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases.

Teddy T C Yang, Qiufang Xiong, Hervé Enslen, Roger J Davis, Chi-Wing Chow

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 175 citations in OpenAlex.

  1. Contrasting the genetic architecture of cardiac glutathione against other organs: unveiling a unique tissue-specific locus.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  2. STIM2β is a CaThe FEBS journal · 2025
    Article
  3. Article
  4. Review
  5. Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  6. Article
  7. Review
  8. How does NFAT3 regulate the occurrence of cardiac hypertrophy?International journal of cardiology. Heart & vasculature · 2023
    Review
  9. Article
  10. Animals : an open access journal from MDPI · 2022
    Article
  11. Review
  12. Ppt1-deficiency dysregulates lysosomal CaJournal of inherited metabolic disease · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. p38β and Cancer: The Beginning of the Road.International journal of molecular sciences · 2020
    Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Teddy T C YangDepartment of Molecular Pharmacology, Jack and Pearl Resnick Campus, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Qiufang Xiong
Hervé Enslen
Roger J Davis
Chi-Wing Chow
Albert Einstein College of Medicine · USHoward Hughes Medical Institute · US

Funding

Molecular Basis of NFAT in Adipocyte DifferentiationR01DK063167 · NIDDK · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI CHOW, CHI-WING · 2004 to 2008
$1.4M
NIDDK NIH HHS R01 DK063167
6 · The paper itself

Abstract

Nuclear factor of activated T cells (NFAT) is implicated in multiple biological processes, including cytokine gene expression, cardiac hypertrophy, and adipocyte differentiation. A conserved NFAT homology domain is identified in all NFAT members. Dephosphorylation of the NFAT homology region is critical for NFAT nuclear translocation and transcriptional activation. Here we demonstrate that NFATc4 is phosphorylated by p38 mitogen-activated protein (MAP) kinase but not by JNK. The p38 MAP kinase phosphorylates multiple residues, including Ser(168) and Ser(170), in the NFAT homology domain of NFATc4. Replacement of Ser(168,170) with Ala promotes nuclear localization of NFATc4 and increases NFAT-mediated transcription activity. Stable expression of Ala(168,170) NFATc4, but not of wild-type NFATc4, in NIH 3T3 cells promotes adipocyte formation under differentiation conditions. Molecular analysis indicates that peroxisome proliferator-activated receptor gamma 2 (PPAR gamma 2) is a target of NFAT. Two distinct NFAT binding elements are located in the PPAR gamma 2 gene promoter. Stable expression of Ala(168,170) NFATc4, but not of wild-type NFATc4, increases the expression of PPAR gamma, which contributes in part to increased adipocyte formation. Thus, NFAT regulates PPAR gamma gene expression and has a direct role in adipocyte differentiation.

Indexed as

Nuclear Proteins3T3 CellsAdipocytesAmino Acid SequenceAmino Acid SubstitutionAnimalsBase SequenceBinding SitesCell DifferentiationCell LineCell NucleusConserved SequenceCOS CellsCricetinaeDNA-Binding ProteinsMiceDNA-Binding ProteinsMitogen-Activated Protein KinasesNFATC4 protein, humanNFATC Transcription FactorsNuclear Proteinsp38 Mitogen-Activated Protein KinasesReceptors, Cytoplasmic and NuclearSerineTranscription Factors

Identifiers

PMID11997522
PMCPMC133816
OpenAlexW1965861063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.